E2F1 and cancer: E2F1 has been reported as an oncogene, and its downregulation by miRNAs has been suggested to reduce malignant behaviors, such as proliferation, invasiveness, and resistance to apoptosis of cancer cells (Han et al., 2020; Lu et al., 2018; Peng et al., 2020).